DIBBS #SPE2DP-26-T-5308

DLA procurement of 30 testosterone cypionate injection vials

DLA is seeking 30 vials of testosterone cypionate injection for delivery to Kadena Air Base in Okinawa, Japan. - Government buyer: Defense Logistics Agency (DLA), DLA Troop Support, Medical Supply Chain Pharm FSA; buyer contact: Vanesa M Carbo Acevedo. - Product: 30 single-dose 1 mL vials of testosterone cypionate injection, USP, 200 mg/mL; NSN 6505-01-028-2086. Each unit is one vial. - Named approved-source manufacturers/vendors: Hikma Pharmaceuticals USA Inc. (NDC 00143-9659-01), Wilshire Pharmaceuticals, Inc. (NDC 52536-0625-01), American Regent Inc. (NDC 00517-1830-01), Cipla USA Inc. (NDC 69097-0802-32), Pfizer Inc. (NDCs 00009-0417-01 and 00409-6562-01), Pfizer Pharmaceuticals (NDC 00009-0417-01), and Padagis Sourcing Solutions LLC (NDC 00574-0827-01). The notice also has an additional entry for NDC 00009-0417-01 without a company name. - Delivery and product requirements: FOB destination to Kadena Air Base, Okinawa, Japan, within 20 days after order. The medication is DEA Schedule III and must have a 24-month non-extendable shelf life. - Period of performance: Supply delivery is required within 20 days after order; no separate contract term or option period is stated.

Description

TESTOSTERONE CYPION (QTY: 30, NSN: 6505-01-028-2086, Purchase Request: 7004550191) Approved Sources: - CAGE: 00YG0, Part No: NDC00009-0417-01 - CAGE: 32655, Part No: NDC00143-9659-01, Company: HIKMA PHARMACEUTICALS USA INC. - CAGE: 6UZB0, Part No: NDC52536-0625-01, Company: WILSHIRE PHARMACEUTICALS, INC - CAGE: 7PXG8, Part No: NDC00517-1830-01, Company: AMERICAN REGENT INC - CAGE: 7WV84, Part No: NDC69097-0802-32, Company: CIPLA USA INC - CAGE: 86491, Part No: NDC00009-0417-01, Company: PFIZER INC - CAGE: 86491, Part No: NDC00409-6562-01, Company: PFIZER INC - CAGE: 96BA9, Part No: NDC00574-0827-01, Company: PADAGIS SOURCING SOLUTIONS LLC

View original listing